Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 192,138 | 157,649 | 104,890 | 91,363 | 64,051 |
| Operating Income | -192,138 | -157,649 | -104,890 | -91,363 | -64,051 |
| Interest Expense | 0 | 0 | 3,152 | -11,654 | -13,580 |
| Other Income | -4,400 | 14,383 | 0 | 0 | 0 |
| Pre-tax Income | -196,537 | -143,266 | -108,042 | -79,709 | -50,472 |
| Income Tax | 2,249 | 1,975 | 1,135 | 716 | 83 |
| Net Income Continuous | -198,786 | -145,241 | -109,177 | -80,424 | -50,555 |
| Net Income | $-198,786 | $-145,241 | $-109,177 | $-80,424 | $-50,555 |
| EPS Basic Total Ops | -3.36 | -2.68 | -2.85 | -2.39 | -1.66 |
| EPS Basic Continuous Ops | -3.36 | -2.69 | -2.84 | -2.39 | -1.66 |
| EPS Diluted Total Ops | -3.36 | -2.68 | -2.85 | -2.39 | -1.66 |
| EPS Diluted Continuous Ops | -3.36 | -2.69 | -2.84 | -2.39 | -1.66 |
| EPS Diluted Before Non-Recurring Items | -3.36 | -2.68 | -2.84 | -2.39 | -1.66 |
| EBITDA(a) | $-191,664 | $-157,358 | $-104,611 | $-91,201 | $-63,960 |